GE HEALTHCARE TECHNOLOGIES INC. Net Income (Loss) Available to Common Stockholders, Basic
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Net Income (Loss) Available to Common Stockholders, Basic of $2.08 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-02-04
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-12-31 was $721.00M, a 78.91% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-09-30 was $470.00M, a 25.33% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-06-30 was $428.00M, a 2.39% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for the quarter ending 2024-03-31 was $374.00M, a 97.88% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2025 was $2.08B, a 4.57% increase from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2024 was $1.99B, a 43.90% increase from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2023 was $1.39B, a 27.71% decline from fiscal 2022.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) available to common stockholders, basic for fiscal 2022 was $1.92B, a 14.73% decline from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.08B 10-K · filed 2026-02-04 | |||
| 2024-12-31 | $721.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.19B derived: sum of 2 quarters · filed 2026-02-04 | $1.62B derived: sum of 3 quarters · filed 2026-02-04 | $1.99B 10-K · filed 2026-02-04 |
| 2024-09-30 | $470.00M 10-Q · filed 2024-10-30 | $898.00M derived: sum of 2 quarters · filed 2024-10-30 | $1.27B 10-Q · filed 2024-10-30 | $1.68B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-06-30 | $428.00M 10-Q · filed 2024-07-31 | $802.00M 10-Q · filed 2024-07-31 | $1.21B derived: sum of 3 quarters · filed 2026-02-04 | $1.58B derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-03-31 | $374.00M 10-Q · filed 2024-04-30 | $777.00M derived: sum of 2 quarters · filed 2026-02-04 | $1.15B derived: sum of 3 quarters · filed 2026-02-04 | $1.57B derived: sum of 4 quarters · filed 2026-02-04 |
| 2023-12-31 | $403.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $778.00M derived: sum of 2 quarters · filed 2026-02-04 | $1.20B derived: sum of 3 quarters · filed 2026-02-04 | $1.39B 10-K · filed 2026-02-04 |
| 2023-09-30 | $375.00M 10-Q · filed 2024-10-30 | $793.00M derived: sum of 2 quarters · filed 2024-10-30 | $982.00M 10-Q · filed 2024-10-30 | $1.54B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $418.00M 10-Q · filed 2024-07-31 | $607.00M 10-Q · filed 2024-07-31 | $1.16B derived: sum of 3 quarters · filed 2025-02-13 | $1.65B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $189.00M 10-Q · filed 2024-04-30 | $743.00M derived: sum of 2 quarters · filed 2025-02-13 | $1.23B derived: sum of 3 quarters · filed 2025-02-13 | $1.72B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $554.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.04B derived: sum of 2 quarters · filed 2025-02-13 | $1.53B derived: sum of 3 quarters · filed 2025-02-13 | $1.92B 10-K · filed 2025-02-13 |
| 2022-09-30 | $487.00M 10-Q · filed 2023-10-31 | $972.00M derived: sum of 2 quarters · filed 2023-10-31 | $1.36B 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $485.00M 10-Q · filed 2023-07-25 | $874.00M 10-Q · filed 2023-07-25 | ||
| 2022-03-31 | $389.00M 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | $2.25B 10-K · filed 2024-02-06 |